Is PF-00299804-03 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use PF-00299804-03? Is PF-00299804-03 safe for nursing mother and child? Does PF-00299804-03 extracts into breast milk? Does PF-00299804-03 has any long term or short term side effects on infants? Can PF-00299804-03 influence milk supply or can PF-00299804-03 decrease milk supply in lactating mothers?
Answer by DrLact: About PF-00299804-03 usage in lactation
No information is available on the clinical use of PF-00299804-03 during breastfeeding. Because PF-00299804-03 is 98% bound to plasma proteins, the amount in milk is likely to be low. However, because of its potential toxicity in the breastfed infant and its half-life of 70 hours, the manufacturer recommends that breastfeeding be discontinued during PF-00299804-03 therapy and for at least 17 days after the last dose.
Alternate Drugs
Vincristine(Dangerous)
Rituximab(Low Risk)
Tamoxifen(Dangerous)
Mitoxantrone(Dangerous)
Dasatinib(Unsafe)
Bevacizumab(Low Risk)
Thioguanine(Dangerous)
Letrozole(Dangerous)
Mercaptopurine(Safe)
Docetaxel(Dangerous)
Exemestane(Dangerous)
Nilotinib(Unsafe)
Gemcitabine(Dangerous)
Hydroxyurea(Low Risk)
Trastuzumab(Unsafe)
Etoposide(Dangerous)
Doxorubicin(Dangerous)
Erlotinib(Unsafe)
Cyclophosphamide(Dangerous)
Imatinib(Unsafe)
Cisplatin(Unsafe)
Dactinomycin(Dangerous)
Ipilimumab(Unsafe)
Busulfan(Dangerous)
Azelaic Acid(Safe)
Cetuximab(Unsafe)
Nivolumab(Unsafe)
Carboplatin(Dangerous)
Vinblastine(Dangerous)
Pazopanib(Unsafe)
Paclitaxel(Dangerous)
Bleomycin(Dangerous)
Cladribine(Dangerous)
Fluorouracil(Dangerous)
Vinorelbine(Dangerous)
Alemtuzumab(Low Risk)
Dacarbazine(Dangerous)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Nilotinib(Unsafe)
Gemcitabine(Dangerous)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Pazopanib(Unsafe)
Allopurinol(Safe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Pazopanib(Unsafe)